BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10225851)

  • 1. Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization.
    Rang CU; Licht TR; Midtvedt T; Conway PL; Chao L; Krogfelt KA; Cohen PS; Molin S
    Clin Diagn Lab Immunol; 1999 May; 6(3):434-6. PubMed ID: 10225851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice.
    Poulsen LK; Licht TR; Rang C; Krogfelt KA; Molin S
    J Bacteriol; 1995 Oct; 177(20):5840-5. PubMed ID: 7592332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.
    Krogfelt KA; Poulsen LK; Molin S
    Infect Immun; 1993 Dec; 61(12):5029-34. PubMed ID: 8225579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization.
    Poulsen LK; Lan F; Kristensen CS; Hobolth P; Molin S; Krogfelt KA
    Infect Immun; 1994 Nov; 62(11):5191-4. PubMed ID: 7927805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Escherichia coli precursor-16S rRNA processing by mouse intestinal contents.
    Licht TR; Tolker-Nielsen T; Holmstrøm K; Krogfelt KA; Molin S
    Environ Microbiol; 1999 Feb; 1(1):23-32. PubMed ID: 11207715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemostat modeling of Escherichia coli persistence in conventionalized mono-associated and streptomycin-treated mice.
    Rang C; Midtvedt T; Molin S; Chao L
    Can J Microbiol; 2001 Jan; 47(1):86-90. PubMed ID: 15049455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rpoS gene function is a disadvantage for Escherichia coli BJ4 during competitive colonization of the mouse large intestine.
    Krogfelt KA; Hjulgaard M; Sørensen K; Cohen PS; Givskov M
    Infect Immun; 2000 May; 68(5):2518-24. PubMed ID: 10768939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neither motility nor chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large intestine.
    McCormick BA; Laux DC; Cohen PS
    Infect Immun; 1990 Sep; 58(9):2957-61. PubMed ID: 2201640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between congenic Escherichia coli K-12 strains in vivo.
    Onderdonk A; Marshall B; Cisneros R; Levy SB
    Infect Immun; 1981 Apr; 32(1):74-9. PubMed ID: 7012037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of stable cloning vectors that do not segregate from a human fecal Escherichia coli strain in the streptomycin-treated mouse large intestine.
    Burghoff RL; Laux DC; Cohen PS
    Infect Immun; 1990 May; 58(5):1141-5. PubMed ID: 2182534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice.
    Myhal ML; Laux DC; Cohen PS
    Eur J Clin Microbiol; 1982 Jun; 1(3):186-92. PubMed ID: 6756909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small intestinal mucosal cell proliferation and bacterial flora in the conventionalization of the germfree mouse.
    Khoury KA; Floch MH; Hersh T
    J Exp Med; 1969 Sep; 130(3):659-70. PubMed ID: 4896909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine.
    Newman JV; Kolter R; Laux DC; Cohen PS
    Microb Pathog; 1994 Nov; 17(5):301-11. PubMed ID: 7723657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus.
    Wadolkowski EA; Laux DC; Cohen PS
    Infect Immun; 1988 May; 56(5):1030-5. PubMed ID: 3281898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and implantation of Escherichia coli in the intestinal tract.
    Freter R; Brickner H; Fekete J; Vickerman MM; Carey KE
    Infect Immun; 1983 Feb; 39(2):686-703. PubMed ID: 6339389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.
    McCormick BA; Franklin DP; Laux DC; Cohen PS
    Infect Immun; 1989 Oct; 57(10):3022-9. PubMed ID: 2570752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli F-18 makes a streptomycin-treated mouse large intestine colonization factor when grown in nutrient broth containing glucose.
    Cohen PS; Kjelleberg S; Laux DC; Conway PL
    Infect Immun; 1990 May; 58(5):1471-2. PubMed ID: 2182545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ accessibility of Escherichia coli 23S rRNA to fluorescently labeled oligonucleotide probes.
    Fuchs BM; Syutsubo K; Ludwig W; Amann R
    Appl Environ Microbiol; 2001 Feb; 67(2):961-8. PubMed ID: 11157269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.
    Møller AK; Leatham MP; Conway T; Nuijten PJ; de Haan LA; Krogfelt KA; Cohen PS
    Infect Immun; 2003 Apr; 71(4):2142-52. PubMed ID: 12654836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Simple
    Mokszycki ME; Leatham-Jensen M; Steffensen JL; Zhang Y; Krogfelt KA; Caldwell ME; Conway T; Cohen PS
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30291119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.